A Performance Study of (opportunistic) Salpingectomy
Launched by UNIVERSITY HOSPITAL, GHENT · Dec 7, 2022
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a surgical procedure called opportunistic salpingectomy, which involves removing the fallopian tubes in women who are also having surgery to remove their ovaries. The goal is to see how well this procedure is performed during surgery and to find out if there are any factors that might lead to incomplete removal of the fallopian tubes. The researchers also hope to create a helpful instructional video to improve the surgical technique used.
To be eligible for this trial, women aged 65 to 74 who are scheduled for surgery to remove one or both of their ovaries (and possibly their uterus) can participate, as long as they can understand the process and speak Dutch. Participants will go through the surgery in two steps: first, the fallopian tubes will be removed, followed by the removal of the ovaries. It’s important to note that women with certain conditions, such as specific types of cancer or pelvic infections, cannot participate. This trial is currently recruiting participants, and it's a great opportunity to contribute to research that may help improve surgical outcomes for future patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients scheduled for uni- or bilateral adnexectomy. (may be in combination with hysterectomy) AND \* competent to act on itself
- • dutch speaking
- • signed informed consent
- Exclusion Criteria:
- • \* Endometrial cancer or invasive cervical cancer
- • radiotherapy in the pelvis in the medical history
- • (partial) salpingectomy
- • Pelvic Inflammatory Disease
- • Adnexectomy for gender transformation surgery if wish to preserve the ovarian tissue.
- • Surgery in two steps is not safe to perform
- • Pregnancy
About University Hospital, Ghent
University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ghent, , Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials